Rocket Pharmaceuticals, Inc. (RCKT) — 分析师展望 / 分析师共识目标价为. 基于 19 位分析师评级, 共识为 看涨 — 13 买入, 4 持有, 2 卖出.
分析师共识目标价为 $5.00, 上涨空间为 28.9% 相对于当前价格 $3.88.
分析师预估 每股收益(EPS)为 $-2.75 和 营收为 $0.00B (下一财年).
每股收益(EPS)历史表现: 2024: 实际 $-2.73 vs 预期 $-2.75 (超预期 +0.8%). 2025: 实际 $-2.01 vs 预期 $-2.05 (超预期 +2.1%). 分析师准确度: 99%.
RCKT 股票 — 12个月价格预测
$5.00
▲ +28.87% 上涨空间
平均目标价
Based on 19 Wall Street analysts offering 12-month price targets for Rocket Pharmaceuticals, Inc., the price target is $5.00.
平均目标价相对最新价格 $3.88 变动 +28.87%。
RCKT 分析师评级
Buy
基于过去3个月内 19 位分析师对 Rocket Pharmaceuticals, Inc. 的评级
EPS 预测 — RCKT
99%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual –$2.73
vs Est –$2.75
▲ 0.8% off
2025
Actual –$2.01
vs Est –$2.05
▲ 2.2% off
Profitability Outlook
Company has been making losses in all recent fiscal years. EPS is improving but still negative. Analysts expect losses to continue near-term.
营收预测 — RCKT
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
